Literature DB >> 33748929

The Japanese Association of Cardiovascular Intervention and Therapeutics position statement on coronary invasive procedures during the COVID-19 pandemic in Japan.

Yuji Ikari1, Shinichiro Yamada2, Natsuhiko Ehara2, Ken Kozuma2, Toshiro Shinke2, Teruyasu Sugano2, Fumiyasu Seike2, Shinjyo Sonoda2, Junichi Tazaki2, Takafumi Tsuji2, Yoshiaki Mibiki2, Takashi Muramatsu2, Takashi Morita2, Mitsuaki Sawano2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33748929      PMCID： PMC7982308          DOI： 10.1007/s12928-021-00767-6

Source DB:  PubMed          Journal:  Cardiovasc Interv Ther        ISSN： 1868-4297


× No keyword cloud information.
  4 in total

Review 1.  Robotic-assisted percutaneous coronary intervention in the COVID-19 pandemic.

Authors:  Kazunori Yamaji; Yoshiaki Mitsutake; Masaharu Nakano; Takuya Nakamura; Yoshihiro Fukumoto
Journal:  J Cardiol       Date:  2021-08-19       Impact factor: 3.159

2.  Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes.

Authors:  Hirohiko Ando; Kyohei Yamaji; Shun Kohsaka; Hideki Ishii; Hideki Wada; Sumio Yamada; Mitsuaki Sawano; Taku Inohara; Yohei Numasawa; Yuji Ikari; Tetsuya Amano
Journal:  Cardiovasc Interv Ther       Date:  2022-01-12

3.  Safety of clinical engineer-assisted percutaneous coronary intervention.

Authors:  Mitsutoshi Oguri; Hideki Ishii; Takuro Shigematsu; Rin Fujita; Yuichiro Koyama; Takeshi Katagiri; Yoshihiro Ikai; Yusuke Fujikawa; Hiroshi Takahashi; Yoriyasu Suzuki; Toyoaki Murohara
Journal:  Cardiovasc Interv Ther       Date:  2022-08-09

Review 4.  Cardiovascular events and atherosclerosis in patients with type 2 diabetes and impaired glucose tolerance: What are the medical treatments to prevent cardiovascular events in such patients?

Authors:  Hideki Ishii
Journal:  J Diabetes Investig       Date:  2022-04-18       Impact factor: 3.681
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.